NZ754781A - Thrombin inhibitors for treatment of stroke and related coagulative disorders - Google Patents

Thrombin inhibitors for treatment of stroke and related coagulative disorders

Info

Publication number
NZ754781A
NZ754781A NZ754781A NZ75478117A NZ754781A NZ 754781 A NZ754781 A NZ 754781A NZ 754781 A NZ754781 A NZ 754781A NZ 75478117 A NZ75478117 A NZ 75478117A NZ 754781 A NZ754781 A NZ 754781A
Authority
NZ
New Zealand
Prior art keywords
stroke
treatment
seq
peptide
thrombin inhibitors
Prior art date
Application number
NZ754781A
Other languages
English (en)
Inventor
Richard J Payne
Shaun Phillip Jackson
Pereira Pedro Jose Barbosa
Original Assignee
Univ Sydney
The Heart Res Institute Limited
Ibmc Inst De Biologia Molecular E Celular
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2016905231A external-priority patent/AU2016905231A0/en
Application filed by Univ Sydney, The Heart Res Institute Limited, Ibmc Inst De Biologia Molecular E Celular filed Critical Univ Sydney
Publication of NZ754781A publication Critical patent/NZ754781A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
NZ754781A 2016-12-16 2017-12-15 Thrombin inhibitors for treatment of stroke and related coagulative disorders NZ754781A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2016905231A AU2016905231A0 (en) 2016-12-16 Thrombin inhibitors for treatment of stroke and related coagulative disorders
PCT/AU2017/051405 WO2018107247A1 (en) 2016-12-16 2017-12-15 Thrombin inhibitors for treatment of stroke and related coagulative disorders

Publications (1)

Publication Number Publication Date
NZ754781A true NZ754781A (en) 2021-12-24

Family

ID=62557849

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ754781A NZ754781A (en) 2016-12-16 2017-12-15 Thrombin inhibitors for treatment of stroke and related coagulative disorders

Country Status (8)

Country Link
US (1) US11091535B2 (cg-RX-API-DMAC7.html)
EP (1) EP3555116A4 (cg-RX-API-DMAC7.html)
JP (2) JP2020501561A (cg-RX-API-DMAC7.html)
CN (1) CN110139871A (cg-RX-API-DMAC7.html)
AU (1) AU2017376839B2 (cg-RX-API-DMAC7.html)
CA (1) CA3047159A1 (cg-RX-API-DMAC7.html)
NZ (1) NZ754781A (cg-RX-API-DMAC7.html)
WO (1) WO2018107247A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110590911B (zh) * 2019-09-30 2021-10-22 华南理工大学 一种含酪氨酸硫酸化修饰的多肽合成方法及其应用
US20230416341A1 (en) * 2020-06-19 2023-12-28 The University Of Sydney Improved thrombin inhibitors for treatment of thromboembolic conditions
CN114887123B (zh) * 2022-04-18 2023-07-04 南通大学 水蛭素接枝纳米纤维血管支架材料、制备方法与应用
CN119462906B (zh) * 2024-11-11 2026-06-05 北京元启合生科技有限公司 一种酪氨酸硫酸化的重组水蛭素、制备方法及其用途

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4323754C1 (de) * 1993-07-15 1994-12-01 Gruenenthal Gmbh Bifunktionelle Urokinasevarianten mit verbesserten fibrinolytischen Eigenschaften und thrombinhemmender Wirkung
US6759384B1 (en) * 1994-04-26 2004-07-06 Aventis Pharmaceuticals Inc. Factor Xa inhibitors
AU5903000A (en) * 1999-06-29 2001-01-31 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Novel anti-thrombin peptide
EP1240194A2 (en) 1999-11-24 2002-09-18 Sugen, Inc. Novel human protein kinases and protein kinase-like enzymes
EP1425296B1 (de) * 2001-09-10 2011-04-13 Novel Science International GmbH Organische verbindungen mit biologischer wirkung als thrombinhemmer und ihre verwendung
JP3648548B2 (ja) * 2001-10-15 2005-05-18 国立大学法人三重大学 血液凝固阻害活性を有するハマダラカ由来のＡｓ−１蛋白質
DE10301255A1 (de) * 2003-01-15 2004-07-29 Cpi Creative Pharma International Gmbh Organische Verbindungen mit biologischer Wirkung als Thrombinhemmer und ihre Verwendung
EP1856147A4 (en) 2005-02-15 2008-07-02 Apollo Life Sciences Ltd MOLECULE AND CHIMESE MOLECULES THEREOF
US20070298034A9 (en) * 2005-12-09 2007-12-27 Angela Widom Sulfotyrosine specific antibodies and uses therefor
CN100595208C (zh) * 2006-07-31 2010-03-24 浙江中医药大学 硫酸化丝素蛋白的制备方法及其在抗凝血药物上的应用
GB0711779D0 (en) * 2007-06-18 2007-07-25 Univ Singapore Thrombin inhibitor
GB0907698D0 (en) * 2009-05-05 2009-06-10 Univ Singapore Method of modifying serine protease inhibitors
WO2012024543A1 (en) 2010-08-18 2012-02-23 Caris Life Sciences Luxembourg Holdings Circulating biomarkers for disease
US9777123B2 (en) * 2013-05-30 2017-10-03 Virginia Commonwealth University Sulfated beta-O4 low molecular weight lignins
DK3004134T3 (da) 2013-06-04 2019-05-13 Univ Sydney Peptid-ligering
US11279771B2 (en) 2014-09-17 2022-03-22 Novo Nordisk A/S Antibodies capable of binding two epitopes on tissue factor pathway inhibitor (1-161)
US20230416341A1 (en) * 2020-06-19 2023-12-28 The University Of Sydney Improved thrombin inhibitors for treatment of thromboembolic conditions

Also Published As

Publication number Publication date
EP3555116A1 (en) 2019-10-23
US20190367583A1 (en) 2019-12-05
JP2022130527A (ja) 2022-09-06
CN110139871A (zh) 2019-08-16
AU2017376839A1 (en) 2019-07-11
CA3047159A1 (en) 2018-06-21
AU2017376839B2 (en) 2021-01-14
JP2020501561A (ja) 2020-01-23
WO2018107247A1 (en) 2018-06-21
EP3555116A4 (en) 2020-07-22
US11091535B2 (en) 2021-08-17

Similar Documents

Publication Publication Date Title
EP4467650A3 (en) Scaffold proteins
EP3936141A3 (en) Anti-senescence compounds and uses thereof
NZ781143A (en) Anti-vegf protein compositions and methods for producing the same
EA201791238A1 (ru) Способы и композиции, в которых используются варианты полипептидов klotho
ZA202302340B (en) Compositions and methods for treating celiac sprue disease
MX2017015927A (es) Fragmentos mutantes de proteina ras.
UA124343C2 (uk) Капсиди аденоасоційованого вірусу і спосіб його використання
MX2023001877A (es) Meganucleasas dise?adas especificas para secuencias de reconocimiento en el gen pcsk9.
PE20240015A1 (es) Proteinas de fusion gdf15 y usos de estas
EA201792651A1 (ru) Аденовирусные полинуклеотиды и полипептиды
WO2011036443A3 (en) Si protease c- terminal polypeptides and uses thereof for treating inflammation or coagulation disorders
HK1243958A1 (zh) 核酸构建体
MX2018000697A (es) Peptidos anti-inflamatorios y usos de los mismos.
PH12017501520B1 (en) Fusarium toxin-cleaving polypeptide variants, additives containing same, use of same, and method for splitting fusarium toxins
NZ724196A (en) Uti fusion proteins
EP4374913A3 (en) Novel human serum albumin mutant
MX2017016195A (es) Variantes de il-37.
MX2018014966A (es) Peptidos monolipidados resistentes a proteasas.
PH12020552222A1 (en) Immunodominant proteins and fragments in multiple sclerosis
PH12021551055A1 (en) Klk5 inhibitory peptide
EA202091007A1 (ru) Способ снижения времени восстановления высушенных распылением белковых составов
MX2017008994A (es) Formulacion de peptidos inhibidores mk2.
PH12018500468A1 (en) Fusion protein
WO2019103512A3 (ko) 목적 단백질의 발현 효율을 증진시키기 위한 신규한 펩타이드 및 이를 포함하는 융합 단백질
EP3925968A3 (en) Hsp70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell

Legal Events

Date Code Title Description
ASS Change of ownership

Owner name: IBMC (INSTITUTO DE BIOLOGIA MOLECULAR E CELULA, PT

Effective date: 20210813

Owner name: THE HEART RESEARCH INSTITUTE LIMITED, AU

Effective date: 20210813

Owner name: THE UNIVERSITY OF SYDNEY PARRAMATTA ROADTHE UN, AU

Effective date: 20210813

PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 DEC 2023 BY DENNEMEYER + CO. S.A.R.L.

Effective date: 20221205

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 DEC 2024 BY DENNEMEYER + CO. SARL

Effective date: 20231204

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 DEC 2025 BY DENNEMEYER ET CO

Effective date: 20241202

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 DEC 2026 BY DENNEMEYER + CO. SARL

Effective date: 20251209